@article{font2013venous,
  title = {Venous Thromboembolism in Cancer Patients: Comparison of Lung Cancer Patients to Other Solid Tumor Patients in a Prospective Observational Study},
  author = {Carme Font and Marc Campayo and Blanca Farrus2 and Alberto Carmona-Bayonas and Aranzazu Fernández-Martinez and Noemi Reguart and Dolors Tassies and Nuria Viñolas and Joan C Reverter and Pere Gascon},
  year = 2013,
  url = {https://ibimapublishing.com/articles/ACRT/2013/223916/},
  journal = {Advances in Cancer Research & Treatment},
  volume = 2012 (2012),
  pages = 12,
  doi = 10.5171/2012.223916,
  abstract = {Background: Lung cancer (LC) is the most frequent solid tumor diagnosed worldwide and is one of the most common tumors in series of patients with cancer-related venous thromboembolism (VTE). The aim of this study was to analyze the clinical characteristics and outcome of VTE in patients with LC compared to patients with other types of cancer (OC).Patients and Methods: A prospective observational study enrolling consecutive cancer patients with newly diagnosed VTE was performed from May 2006 to April 2009 in our Department of Medical Oncology. All patients were uniformly treated and followed according to the American College of Chest Physicians guidelines. Results: A total of 340 cancer patients were enrolled with LC being the most frequent primary tumor in 89 (26%) patients (69 male; mean age 62 ± 11 years). VTE was diagnosed earlier in patients with LC after the initial cancer diagnosis, with a median of 4 months (95% CI 2.79-5.20) compared to 7 months (95% CI 4.40-9.59) in patients with OC (p<0.0001). The VTE presented as pulmonary embolism in a higher proportion of patients with LC (51% vs 28%, p=0.005) although there were no differences in VTE-related outcomes due to the acute thrombotic event. After a mean follow-up of 14 ± 13 months no significant differences were found in venous re-thrombosis, major-bleeding or causes of death in patients with LC and OC. Conclusion: VTE in patients with LC occurs earlier after cancer diagnosis although no differences in VTE-related outcomes were observed compared to patients with OC.},
  keywords = {Venous thromboembolism; Hypercoagulability; Lung Cancer; Trousseau’s syndrome.},
  note = Article ID: 223916
}